Episurf Medical AB financials
Episurf Medical AB
549300GORBCSMHZB2J75 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | SEK 13.0M | SEK 10.3M |
| Other income | SEK 100.0K | SEK 300.0K |
| Operating expenses | SEK 97.9M | SEK 116.9M |
| Employee benefits expense | SEK 36.5M | SEK 46.6M |
| Depreciation & amortisation | SEK 9.0M | SEK 8.7M |
| Operating profit (EBIT) | -SEK 77.2M | -SEK 96.7M |
| Net finance income / (cost) | SEK 1.3M | SEK 2.2M |
| Finance costs | SEK 1.0M | SEK 900.0K |
| Profit before tax | -SEK 76.0M | -SEK 94.6M |
| Income tax expense | SEK 100.0K | SEK 300.0K |
| Profit for the year | -SEK 76.0M | -SEK 94.8M |
| Total comprehensive income | -SEK 75.9M | -SEK 94.9M |
| Per share | ||
| Basic EPS | SEK -0.15 | SEK -0.30 |
| Diluted EPS | SEK -0.15 | SEK -0.30 |
| Free cash flow / share | SEK -0.14 | SEK -0.27 |
| Cash flow statement | ||
| Net cash from operating activities | -SEK 71.4M | -SEK 84.8M |
| Net cash from investing activities | -SEK 7.6M | -SEK 9.5M |
| Purchase of PP&E (capex) | SEK 0 | SEK 0 |
| Purchase of intangibles | SEK 7.6M | SEK 9.5M |
| Net cash from financing activities | SEK 71.6M | -SEK 3.0M |
| Lease liability payments | SEK 2.4M | SEK 3.2M |
| Balance sheet | ||
| Total assets | SEK 97.8M | SEK 104.3M |
| Non-current assets | SEK 38.0M | SEK 39.3M |
| Right-of-use assets | SEK 2.8M | SEK 5.6M |
| Current assets | SEK 59.7M | SEK 65.0M |
| Inventories | SEK 3.2M | SEK 3.7M |
| Trade & other receivables | SEK 2.2M | SEK 1.4M |
| Cash & equivalents | SEK 50.5M | SEK 57.9M |
| — attributable to owners | SEK 83.8M | SEK 84.5M |
| Non-current liabilities | SEK 0 | SEK 2.4M |
| Lease liabilities (non-current) | SEK 0 | SEK 2.3M |
| Current liabilities | SEK 13.9M | SEK 17.4M |
| Lease liabilities (current) | SEK 2.3M | SEK 2.9M |
| Derived metrics | ||
| Free cash flow | -SEK 71.4M | -SEK 84.8M |
| Operating margin | -593.8% | -938.8% |
| Net margin | -584.6% | -920.4% |
| Return on equity | -90.7% | -112.2% |
| Cash conversion ratio | 0.94× | 0.89× |
| Other reported items | ||
| Additional Paidin Capital | SEK 832.6M | SEK 684.8M |
| Adjustments For Decrease Increase In Inventories | SEK 500.0K | -SEK 1.8M |
| Adjustments For Decrease Increase In Other Operating Receivables | -SEK 1.8M | SEK 0 |
| Adjustments For Decrease Increase In Trade Account Receivable | -SEK 800.0K | SEK 400.0K |
| Adjustments For Depreciation and Amortisation Expense | SEK 9.0M | SEK 8.7M |
| Adjustments For Increase Decrease In Other Operating Payables | -SEK 3.3M | SEK 2.2M |
| Adjustments For Sharebased Payments | SEK 1.0M | SEK 700.0K |
| Cash Flows From Used In Operations Before Changes In Working Capital | -SEK 65.9M | -SEK 85.6M |
| Comprehensive Income Attributable To Owners of Parent | -SEK 75.9M | -SEK 94.9M |
| Cost of Merchandise Sold | SEK 9.9M | SEK 7.3M |
| Current Accruals and Current Deferred Income Including Current Contract Liabilities | SEK 6.7M | SEK 6.4M |
| Current Prepayments and Current Accrued Income Including Current Contract Assets | SEK 2.6M | SEK 1.5M |
| Equity and Liabilities | SEK 97.8M | SEK 104.3M |
| Finance Income | SEK 2.2M | SEK 3.1M |
| Increase Decrease In Cash and Cash Equivalents | -SEK 7.4M | -SEK 97.4M |
| Increase Decrease In Working Capital | SEK 5.5M | -SEK 700.0K |
| Intangible Assets Other Than Goodwill | SEK 35.2M | SEK 33.7M |
| Interest Paid Classified As Operating Activities | SEK 1.0M | SEK 600.0K |
| Interest Received Classified As Operating Activities | SEK 2.2M | SEK 2.3M |
| Issued Capital | SEK 6.5M | SEK 80.2M |
| Liabilities | SEK 13.9M | SEK 19.8M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | SEK 200.0K | -SEK 100.0K |
| Other Current Liabilities | SEK 1.6M | SEK 1.9M |
| Other Current Receivables | SEK 1.3M | SEK 500.0K |
| Other Expense By Nature | SEK 42.5M | SEK 54.3M |
| Other Noncurrent Liabilities | SEK 0 | SEK 200.0K |
| Other Reserves | -SEK 100.0K | -SEK 300.0K |
| Other Work Performed By Entity and Capitalised | SEK 7.6M | SEK 9.5M |
| Payments For Share Issue Costs | SEK 16.2M | SEK 0 |
| Proceeds From Exercise of Options | SEK 0 | SEK 200.0K |
| Proceeds From Issuing Shares | SEK 90.2M | SEK 0 |
| Retained Earnings | -SEK 755.2M | -SEK 680.2M |
| Trade and Other Current Payables To Trade Suppliers | SEK 3.2M | SEK 6.1M |
| Weighted Average Shares | 494.8M | 314.2M |
Every line item above is a fact tagged in Episurf Medical AB's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (SEK), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.